Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Recenti Progressi in Medicina|April 9, 2008
[Advances in biologic therapy for inflammatory bowel disease]Raffaello Sostegni, Angelo Pera, Marco Daperno, et al.European Journal of Internal Medicine|September 1, 2000
Genotype-phenotype relationship in inflammatory bowel diseasePera, Sostegni, Daperno, et al.Acta Bio-Medica : Atenei Parmensis|November 11, 2011
A rare location of Crohn's disease: the nasal mucosaRinaldo Pellicano, Raffaello Sostegni, Carlo Sguazzini, et al.Soft Matter|May 3, 2014
Biocompatible cationic lipids for the formulation of liposomal DNA vectorsCostanza Montis, Silvia Sostegni, Silvia Milani, et al.European Journal of Gynaecological Oncology|March 31, 2010
Possible role of palliative surgery for bowel obstruction in advanced ovarian cancer patientsE Sartori, F Chiudinelli, B Pasinetti, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 2, 2013
Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective studyAngiolo Gadducci, Stefania Cosio, Paolo Zola, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 31, 2002
Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patientsA Kohn, C Prantera, A Pera, et al.Alimentary Pharmacology & Therapeutics|June 6, 2003
Review article: Crohn's disease: monitoring disease activityR Sostegni, M Daperno, N Scaglione, et al.European Review for Medical and Pharmacological Sciences|January 11, 2005
Infliximab in the treatment of severe ulcerative colitis: a follow-up studyA Kohn, C Prantera, A Pera, et al.Minerva Chirurgica|August 23, 2000
[Stricture plasty in Crohn's disease. Indications and results]A Resegotti, M Astegiano, R Sostegni, et al.Pageof 5